SUMMARY. This week we continued to see states beginning to reopen their economies in a limited way. We remain focused on the pace of states reopening, monitoring this very closely, as well as drug therapy/vaccine trials which hold the fastest way to reduce fear so economic growth can resume.
INVESTMENT IMPACT. Our model portfolios remained weighted towards those companies who's valuations (in our view) have been slow to reflect the reopening of the economy. We remind clients, it was always our belief that the virus would defer growth not end it and was reduced growth is transitory not permanent. Our conviction of this was partly tied to our extensive research on drug therapies which we thought would work to thwart the spread and reduce deaths.
For more insights see our website and disclosures found there at BCA. As always contact us for further explanation of how these events can effect your finances.